(Q34099645)

31 July 2017

1 reference

title

Molecular aspects of lipoic acid in the prevention of diabetes complications. (English)

1 reference

complications of diabetes mellitus

31 July 2017

1 reference

1 reference

Packer L

1

1 reference

31 July 2017

Kraemer K

series ordinal

2

1 reference

31 July 2017

Rimbach G

series ordinal

3

1 reference

31 July 2017

language of work or name

1 reference

1 October 2001

1 reference

31 July 2017

1 reference

31 July 2017

17

1 reference

31 July 2017

888-895

1 reference

31 July 2017

10

1 reference

Growth factors for bacteria: Fractionation and properties of an accessory factor for lactic acid bacteria

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Crystalline alpha-lipoic acid; a catalytic agent associated with pyruvate dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Biosynthesis of lipoic acid and posttranslational modification with lipoic acid in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Why do mitochondria synthesize fatty acids? Evidence for involvement in lipoic acid production

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Influence of food intake on the bioavailability of thioctic acid enantiomers

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Dose-proportionality of oral thioctic acid--coincidence of assessments via pooled plasma and individual data

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Lipoic acid metabolism in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

The role of lipoic acid in the treatment of diabetic polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Effect of lipoic acid on biliary excretion of glutathione and metals

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant?

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Protective role of DL-alpha-lipoic acid against mercury-induced neural lipid peroxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Alpha-lipoic acid supplementation prevents symptoms of vitamin E deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and one-electron reduction of ubisemiquinone

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Regulation of cellular thiols in human lymphocytes by alpha-lipoic acid: a flow cytometric analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

The standard redox potential of cysteine-cystine from the thiol-disulphide exchange reaction with glutathione and lipoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Free radicals and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

The role of oxidative stress in neuropathy and other diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Oxidative stress and diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Relationships between plasma measures of oxidative stress and metabolic control in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Increased oxidative damage to all DNA bases in patients with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Molecular therapies for vascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

The role of endothelium in cardiovascular homeostasis and diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Is NF-kappaB the sensor of oxidative stress?

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Redox signaling and the emerging therapeutic potential of thiol antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

alpha-Lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Antioxidant regulation of phorbol ester-induced adhesion of human Jurkat T-cells to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Lipoate prevents glucose-induced protein modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Alpha-lipoic acid provides neuroprotection from ischemia-reperfusion injury of peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Effect of DL-alpha-lipoic acid on the citrate concentration and phosphofructokinase activity of perfused hearts from normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Modulation of cellular reducing equivalent homeostasis by alpha-lipoic acid. Mechanisms and implications for diabetes and ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Inhibition of gluconeogenesis in rat liver by lipoic acid. Evidence for more than one site of action

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Identification of biotin sulfone, bisnorbiotin methyl ketone, and tetranorbiotin-l-sulfoxide in human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Dose/response curves of lipoic acid R-and S-forms in the working rat heart during reoxygenation: superiority of the R-enantiomer in enhancement of aortic flow

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

The inhibitory effects of lipoic compounds on mammalian pyruvate dehydrogenase complex and its catalytic components

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

Decrease of red cell membrane fluidity and -SH groups due to hyperglycemic conditions is counteracted by alpha-lipoic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900658-X

7 January 2021

10.1016/S0899-9007(01)00658-X

Identifiers

DOI

1 reference

release_mop7rpg23fhf3ksabio2hlzkmu

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mop7rpg23fhf3ksabio2hlzkmu

24 November 2022

mapped directly with Wikidata item

1 reference